Eikon Therapeutics, Inc. EIKN

US Biotechnology

$6.17 ▲ +5.11% (+$0.30)

⬆️ Above Yest. High 🔥 High Short Interest 📅 Earnings This Week

Open $5.83

Prev Close $5.87

Day Range $5.73 – $6.34

52W Range $5.01 – $17.40

Market Cap $317.95M

Beta 1.58

EPS (TTM) $-10.10

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2026-02-05
Shares Out.	54,170,000
Website	eikontx.com ↗
Phone	13026587581
Employees	384
Revenue	$0
Gross Profit	$0
Net Income	-$88.4M
Total Assets	$779.6M
Total Liabilities	$313.1M
Equity	$466.5M

About Eikon Therapeutics, Inc.

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Eikon Therapeutics, Inc. is a publicly traded company under the ticker symbol EIKN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.